BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21156098)

  • 1. Assessment of varicella vaccine effectiveness in Germany: a time-series approach.
    Höhle M; Siedler A; Bader HM; Ludwig M; Heininger U; Von Kries R
    Epidemiol Infect; 2011 Nov; 139(11):1710-9. PubMed ID: 21156098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of vaccine-induced immunity to varicella over time.
    Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
    N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany.
    Siedler A; Arndt U
    Euro Surveill; 2010 Apr; 15(13):. PubMed ID: 20394710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of varicella after implementation of routine childhood varicella vaccination in Germany.
    Spackova M; Muehlen M; Siedler A
    Pediatr Infect Dis J; 2010 Sep; 29(9):884-6. PubMed ID: 20442685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of varicella vaccination in children in Germany: a case-control study.
    Liese JG; Cohen C; Rack A; Pirzer K; Eber S; Blum M; Greenberg M; Streng A
    Pediatr Infect Dis J; 2013 Sep; 32(9):998-1004. PubMed ID: 23694831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.
    Baxter R; Ray P; Tran TN; Black S; Shinefield HR; Coplan PM; Lewis E; Fireman B; Saddier P
    Pediatrics; 2013 May; 131(5):e1389-96. PubMed ID: 23545380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaanalysis of vaccine effectiveness in varicella outbreaks.
    Bayer O; Heininger U; Heiligensetzer C; von Kries R
    Vaccine; 2007 Sep; 25(37-38):6655-60. PubMed ID: 17706845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015.
    Rieck T; Feig M; An der Heiden M; Siedler A; Wichmann O
    Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28488996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
    Pozza F; Piovesan C; Russo F; Bella A; Pezzotti P; Emberti Gialloreti L
    Vaccine; 2011 Nov; 29(51):9480-7. PubMed ID: 22015389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
    Spackova M; Wiese-Posselt M; Dehnert M; Matysiak-Klose D; Heininger U; Siedler A
    Vaccine; 2010 Jan; 28(3):686-91. PubMed ID: 19874924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Australia's varicella vaccination program for children and adolescents.
    Ward K; Dey A; Hull B; Quinn HE; Macartney K; Menzies R
    Vaccine; 2013 Feb; 31(10):1413-9. PubMed ID: 23290837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella vaccine effectiveness in the US vaccination program: a review.
    Seward JF; Marin M; Vázquez M
    J Infect Dis; 2008 Mar; 197 Suppl 2():S82-9. PubMed ID: 18419415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness over time of varicella vaccine.
    Vázquez M; LaRussa PS; Gershon AA; Niccolai LM; Muehlenbein CE; Steinberg SP; Shapiro ED
    JAMA; 2004 Feb; 291(7):851-5. PubMed ID: 14970064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.